The first issue of Uppsala Reports for the year is now available online, featuring medicines safety articles by field experts and representatives from UMC and the WHO Programme for International Drug Monitoring.
Issue 78, published in April 2018, showcases a long-read article about medicinal plant nomenclature and how inconsistently named herbals can wreak havoc in the regulation and safety monitoring of these medicines.
The issue also includes event updates from Latin America, Asia, the Middle East, and Africa; a feature article from Brazil about a system to prevent medication errors; news regarding UMC’s research, tools, and methods; an opinion piece by UMC’s former director Prof Ralph Edwards; and much more.
Get a glimpse of some of the highlights below, and read the full issue online here.
Navigating the plant-names jungle
Inconsistent use of names for medicinal plants and plant-based drugs can have serious health consequences and impede efforts to analyse adverse drug reactions to herbal medicines. Kew Gardens’ Medicinal Plant Names Services enables scientific rigour in the regulation, coding, and use of herbals. By Dr Bob Allkin and Kristina Patmore, Royal Botanic Gardens, Kew.
Uganda welcomes the world to 40th annual meeting
In November 2017, the shores of Lake Victoria drew representatives from 60 national pharmacovigilance centres to the 40th annual meeting of the WHO Programme for International Drug Monitoring. By Geoffrey Bowring, UMC.
Q&A: Bhutan’s climb to medicines safety
The outlook is good for pharmacovigilance in Bhutan, Ms Tshering Choden – one of only five pharmacovigilance professionals in the country – tells Uppsala Reports in this Q&A. By Alexandra Hoegberg, UMC.
Better signal detection with vigiRank
By factoring in the content and quality – not just the quantity – of adverse drug reaction reports, UMC’s vigiRank algorithm reliably flags potential signals for further investigation. By Dr Ola Caster, UMC.
Brazilian hospital’s early action system prevents medication errors
At the Hospital Estadual Sumaré, extra safety measures have been established to avoid medication errors, and an ME-prevention method based on the principles of signal detection is being investigated. By Prof Maurício Perroud, School of Medical Sciences & Hospital Estadual Sumaré at Unicamp.
Opinion: Living with complexity and big data
In causal dispositionalism, the characteristics of both medicines and patients are considered when estimating probable beneficial or adverse outcomes of treatments. This opinion article outlines how this approach can be applied to causality in pharmacovigilance. By Prof Ralph Edwards, UMC.
Social media campaign raises awareness of ADR reporting
Uppsala Monitoring Centre teamed up with medicine regulatory authorities in 27 countries to launch a social media awareness campaign on the importance of reporting adverse drug reactions. By the Global Communications team, UMC.
Subscribe to get future issues free of charge directly to your inbox.
View all issues of Uppsala Reports in the archive.